Chris Duncombe

2.8k total citations
34 papers, 1.2k citations indexed

About

Chris Duncombe is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Chris Duncombe has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 19 papers in Virology and 12 papers in Emergency Medicine. Recurrent topics in Chris Duncombe's work include HIV/AIDS Research and Interventions (21 papers), HIV Research and Treatment (19 papers) and HIV/AIDS drug development and treatment (16 papers). Chris Duncombe is often cited by papers focused on HIV/AIDS Research and Interventions (21 papers), HIV Research and Treatment (19 papers) and HIV/AIDS drug development and treatment (16 papers). Chris Duncombe collaborates with scholars based in Thailand, Australia and United States. Chris Duncombe's co-authors include Shanthi Pal, Sten Olsson, Dennis Falzon, David A. Cooper, Praphan Phanuphak, Kiat Ruxrungtham, Gregory J. Dore, David Hoos, Mark Boyd and Apicha Mahanontharit and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Chris Duncombe

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Duncombe Thailand 17 826 439 399 189 162 34 1.2k
Jennifer Cocohoba United States 24 1.0k 1.2× 255 0.6× 466 1.2× 306 1.6× 88 0.5× 62 1.5k
Mark S. Shaefer United States 24 1.5k 1.8× 1.1k 2.4× 419 1.1× 438 2.3× 222 1.4× 79 2.4k
Paul A. Pham United States 17 1000 1.2× 507 1.2× 457 1.1× 375 2.0× 135 0.8× 38 1.5k
John Idoko Nigeria 21 771 0.9× 260 0.6× 625 1.6× 140 0.7× 120 0.7× 78 1.3k
Albert Mwango United States 15 1.4k 1.7× 536 1.2× 544 1.4× 338 1.8× 372 2.3× 22 1.6k
Colette Smit Netherlands 16 912 1.1× 360 0.8× 782 2.0× 685 3.6× 44 0.3× 49 1.6k
Richard Kaplan South Africa 26 1.8k 2.1× 715 1.6× 835 2.1× 285 1.5× 172 1.1× 52 2.0k
Mark Mirochnick United States 25 1.2k 1.4× 516 1.2× 423 1.1× 278 1.5× 633 3.9× 61 2.0k
Sara Lodi United States 18 534 0.6× 248 0.6× 473 1.2× 84 0.4× 46 0.3× 69 1.0k
Natella Rakhmanina United States 21 836 1.0× 351 0.8× 281 0.7× 168 0.9× 338 2.1× 95 1.3k

Countries citing papers authored by Chris Duncombe

Since Specialization
Citations

This map shows the geographic impact of Chris Duncombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Duncombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Duncombe more than expected).

Fields of papers citing papers by Chris Duncombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Duncombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Duncombe. The network helps show where Chris Duncombe may publish in the future.

Co-authorship network of co-authors of Chris Duncombe

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Duncombe. A scholar is included among the top collaborators of Chris Duncombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Duncombe. Chris Duncombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sikazwe, Izukanji, Ingrid Eshun‐Wilson, Kombatende Sikombe, et al.. (2019). Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach. PLoS Medicine. 16(5). e1002811–e1002811. 43 indexed citations
3.
Duncombe, Chris, Nicholas S. Hellmann, Charles B. Holmes, et al.. (2015). Reframing HIV care: putting people at the centre of antiretroviral delivery. Tropical Medicine & International Health. 20(4). 430–447. 142 indexed citations
4.
Winston, Alan, Rebekah Puls, Stephen J. Kerr, et al.. (2015). Differences in the Direction of Change of Cerebral Function Parameters Are Evident over Three Years in HIV-Infected Individuals Electively Commencing Initial cART. PLoS ONE. 10(2). e0118608–e0118608. 10 indexed citations
5.
Pal, Shanthi, Chris Duncombe, Dennis Falzon, & Sten Olsson. (2013). WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems. Drug Safety. 36(2). 75–81. 172 indexed citations
6.
Kerr, Stephen J., Anchalee Avihingsanon, Opass Putcharoen, et al.. (2012). Assessing adherence in Thai patients taking combination antiretroviral therapy. International Journal of STD & AIDS. 23(3). 160–165. 15 indexed citations
7.
Duncombe, Chris, et al.. (2012). Treatment 2.0. Current Opinion in HIV and AIDS. 8(1). 4–11. 9 indexed citations
8.
Winston, Alan, Chris Duncombe, Patrick CK Li, et al.. (2012). Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy. Neuroradiology. 54(12). 1331–1339. 7 indexed citations
9.
Bakare, Nyasha, I. Ralph Edwards, Andy Stergachis, et al.. (2011). Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities. PLoS Medicine. 8(7). e1001054–e1001054. 16 indexed citations
10.
11.
Puls, Rebekah, Preeyaporn Srasuebkul, Kathy Petoumenos, et al.. (2010). Efavirenz versus Boosted Atazanavir or Zidovudine and Abacavir in Antiretroviral Treatment–Naive, HIV‐Infected Subjects: Week 48 Data from the Altair Study. Clinical Infectious Diseases. 51(7). 855–864. 46 indexed citations
12.
Gayet‐Ageron, Angèle, Chris Duncombe, Thidarat Jupimai, et al.. (2008). Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure. PubMed. 2(1). 69–73. 1 indexed citations
13.
Boom, Jan, Chris Duncombe, Stephen J. Kerr, et al.. (2007). Ferritin levels during structured treatment interruption of highly active antiretroviral therapy. HIV Medicine. 8(6). 388–395. 15 indexed citations
14.
Avihingsanon, Anchalee, Yingyos Avihingsanon, Stephen J. Kerr, et al.. (2006). High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.. PubMed. 89 Suppl 2. S21–7. 4 indexed citations
15.
Duncombe, Chris, Stephen J. Kerr, Kiat Ruxrungtham, et al.. (2005). HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting. AIDS. 19(2). 169–178. 22 indexed citations
16.
Ananworanich, Jintanat, Umaporn Siangphoe, Jason R. Chan, et al.. (2005). Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs. AIDS. 19(2). 185–192. 61 indexed citations
17.
Law, W. Phillip, Gregory J. Dore, Chris Duncombe, et al.. (2003). Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001. AIDS. 17(15). 2191–2199. 87 indexed citations
18.
Kaufmann, Gilbert R., Chris Duncombe, John Zaunders, Philip Cunningham, & D.N. Cooper. (1998). Primary HIV-1 Infection: A Review of Clinical Manifestations, Immunologic and Virologic Changes. AIDS Patient Care and STDs. 12(10). 759–767. 15 indexed citations
19.
Kaufmann, Gilbert R., Chris Duncombe, Philip Cunningham, et al.. (1998). Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals. AIDS. 12(13). 1625–1630. 43 indexed citations
20.
Imrie, Allison, Andrew Carr, Chris Duncombe, et al.. (1996). Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Does Not Adversely Affect Outcome at 1 Year. The Journal of Infectious Diseases. 174(1). 195–198. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Cocohoba Breakdown of academic impact, for papers by Mark S. Shaefer Breakdown of academic impact, for papers by Paul A. Pham Breakdown of academic impact, for papers by John Idoko Breakdown of academic impact, for papers by Albert Mwango Breakdown of academic impact, for papers by Colette Smit Breakdown of academic impact, for papers by Richard Kaplan Breakdown of academic impact, for papers by Mark Mirochnick Breakdown of academic impact, for papers by Sara Lodi Breakdown of academic impact, for papers by Natella Rakhmanina
Rankless by CCL
2026